Latest filing published 28 May 2026 for Bausch & Lomb Corp, €215k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Sarah B. Kavanagh across 2 companies, led by Bausch & Lomb Corp and Bausch Health Companies Inc. Between 30 April 2021 and 26 May 2026, the trades on record add up to 12 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 28 May 2026, the filings show a share grant worth €215k in Bausch & Lomb Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations